Class II
Ongoing
Cetrorelix Acetate for Injection (Kit), 0.25 mg per vial, Single-Dose Kit, Rx Only, Mfd. for: Meitheal Pharmaceuticals, Chicago, IL NDC 71288-558-90.
This recall is currently active, issued February 18, 2026. It was issued by Meitheal Pharmaceuticals Inc.
- Company
- Meitheal Pharmaceuticals Inc
- Recall Initiated
- February 9, 2026
- Posted
- February 18, 2026
- Recall Number
- D-0340-2026
- Voluntary / Mandated
- Voluntary: Firm initiated
- Quantity
- 16,477 kits
- Firm Location
- Chicago, IL, United States
- Official Source
- View on FDA website ↗
Reason for Recall
Defective Delivery System: Missing or duplicated needles within the injection kit
Distribution
U.S. Nationwide
Lot / Code Info
Lot Q4E0112A, Exp.: 30 Apr 2027
More recalls by Meitheal Pharmaceuticals Inc
Other recent Class II Drug recalls
Vista Tears Polyethylene Glycol 400 0.4% w/v, Propylene Glycol 0.3% w/v Eye Drops, Dry Eye Relief, L...
Wizcure Pharmaa Private Limited
· Mar 4, 2026
Amantadine HCl, Capsules, UPS, 100 mg, 50 Capsules (5 x 10) unit dose, Rx Only, Manufactured for: Av...
Avkare
· Mar 4, 2026
Agebox iKids-Growth (Day Formula) capsules, 60-count bottles, Manufactured Exclusively For: AGEBOX I...
Agebox
· Mar 4, 2026
Adbry, (tralokinumab-ldrm) injection, 300 mg/2mL, Packaged as a) 1 x Single dose Autoinjector, SAMPL...
Leo Pharma Inc
· Mar 4, 2026
Pro Numb Tattoo Numbing Spray, For Sensitive Skin, 4% Lidocaine, [1FL OZ/28.4 ML or 4 oz/120 mL] per...
Pro Numb Tattoo Numbing Spray Llc
· Feb 18, 2026